Literature DB >> 21251990

Electroporation-mediated gene transfer of SOX trio to enhance chondrogenesis in adipose stem cells.

G-I Im1, H-J Kim.   

Abstract

OBJECTIVE: The aim of the present study was to determine if the electroporation-mediated gene transfer of SOX trio enhances the chondrogenic potential of adipose stem cells (ASCs).
DESIGN: ASCs were transfected with SOX trio genes using an electroporation technique and cultured for 3 weeks. The pellets were analyzed for DNA and glycosaminoglycan (GAG) analysis, and the gene and protein expression of SOX-5, SOX-6, SOX-9, type 1 collagen (COL1Al), type 2 collagen (COL2Al) and type 10 collagen (COL10A1) using real-time PCR and Western blot analysis. Further in vivo studies were carried out by subcutaneous transplantation of pellets in severe combined immunodeficiency (SCID) mice for 3 weeks.
RESULTS: The gene transfer efficiency was high (approximately 70%). Transfected ASCs showed high expression of corresponding genes after 21 days, and each SOX protein was detected in ASCs transfected with the corresponding gene. The chondrogenic differentiation of ASCs, as demonstrated by GAG levels and Safranin-O staining, showed significant enhancement when SOX trio were co-transfected, while subsets with single gene transfer of SOX-5, -6, or -9 did not show significant elevation. SOX trio co-transfection enhanced COL2A1 mRNA, but did not increase COL1A1 and COL10A1 mRNA. Type II collagen protein dramatically increased, and type X collagen decreased with co-transfection of the SOX trio. When pellets were implanted in the subcutaneous pouch of SCID mice for 3 weeks, ASCs co-transfected with SOX trio demonstrated abundant proteoglycan, significantly reduced mineralization.
CONCLUSION: The electroporation-mediated transfection of SOX trio greatly enhances chondrogenesis from ASCs, while decreasing hypertrophy.
Copyright © 2011 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21251990     DOI: 10.1016/j.joca.2011.01.005

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  7 in total

Review 1.  Synthetic development: building mammalian multicellular structures with artificial genetic programs.

Authors:  Marco Santorelli; Calvin Lam; Leonardo Morsut
Journal:  Curr Opin Biotechnol       Date:  2019-05-23       Impact factor: 9.740

2.  Nucleofection induces transient eIF2α phosphorylation by GCN2 and PERK.

Authors:  B R Anderson; K Karikó; D Weissman
Journal:  Gene Ther       Date:  2012-02-02       Impact factor: 5.250

Review 3.  DNA Methylation in Osteoarthritis: Current Status and Therapeutic Implications.

Authors:  Antonio Miranda-Duarte
Journal:  Open Rheumatol J       Date:  2018-03-30

4.  Minicircle Mediated Gene Delivery to Canine and Equine Mesenchymal Stem Cells.

Authors:  Naomie Tidd; Jacob Michelsen; Bryan Hilbert; Jane C Quinn
Journal:  Int J Mol Sci       Date:  2017-04-12       Impact factor: 5.923

5.  Mesenchymal stem cells genetically engineered to express platelet-derived growth factor and heme oxygenase-1 ameliorate osteoarthritis in a canine model.

Authors:  Jiwon Oh; Yeon Sung Son; Wan Hee Kim; Oh-Kyeong Kwon; Byung-Jae Kang
Journal:  J Orthop Surg Res       Date:  2021-01-11       Impact factor: 2.359

6.  Transcription regulators differentiate mesenchymal stem cells into chondroprogenitors, and their in vivo implantation regenerated the intervertebral disc degeneration.

Authors:  Shumaila Khalid; Sobia Ekram; Asmat Salim; G Rasul Chaudhry; Irfan Khan
Journal:  World J Stem Cells       Date:  2022-02-26       Impact factor: 5.326

Review 7.  Minicircles for Investigating and Treating Arthritic Diseases.

Authors:  Yeri Alice Rim; Yoojun Nam; Narae Park; Ji Hyeon Ju
Journal:  Pharmaceutics       Date:  2021-05-17       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.